Edited by Kenneth C. Shadlen, London School of Economics and Political Science, UK, Samira Guennif, Université Paris 13, France, Alenka Guzmán, Autonomous Metropolitan University-Iztapalapa, Mexico and Narayanan Lalitha, Gujarat Institute of Development Research, India

• Contents:1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International EnvironmentKenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha2. Pharmaceutical Production and Access to Essential Medicines in South AfricaHeinz Klug3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy Gaëlle Krikorian4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in ColombiaTatiana Andia5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPSAlenka Guzmán6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS ProgramMatthew Flynn7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health PoliciesKenneth C. Shadlen8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian ExperienceJean-Frédéric Morin and Mélanie Bourassa Forcier9. Access to Indian Generic Drugs: Emerging IssuesN. Lalitha10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in ChinaMariko Watanabe and Luwen Shi11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing CountrySamira Guennif12. The TRIPS Agreement and Health Innovation in BangladeshPadmashree Gehl Sampath Index

‘. . . this book will appeal strongly to a wide range of professionals, academics and students with interest in and involvement in public health issues worldwide, specifically the pharmaceutical industry. . . the book is timely, topical, and packed with carefully researched information which puts a number of major issues relating to pharmaceuticals in perspective. Of great value to researchers are the copious footnotes and extensive bibliographies which follow most of the articles. . . this book certainly provides you with an impressive mine of information if you find yourself having to argue your corner on any number of legal, economic and ethical issues in this complex field of study.’